Corvus Pharmaceuticals
CRVS
CRVS
92 hedge funds and large institutions have $167M invested in Corvus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 9 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+5
Holders Change %
+5.75%
% of All Funds
1.23%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
33
Increased
32
Reduced
9
Closed
28
Calls
$702K
Puts
$1.01M
Net Calls
-$308K
Net Calls Change
-$3.1M
Top Buyers
1 |
Point72 Asset Management
Stamford,
Connecticut
|
$28.2M |
2 |
BlackRock
New York
|
$17M |
3 |
PA
Perceptive Advisors
New York
|
$5.75M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
$13.1M |
5 |
Geode Capital Management
Boston,
Massachusetts
|
$5.45M |